David Reardon, MD

Medical Oncology

David Reardon, MD

View Full Profile

Related Videos

ASCO22: Glioblastoma research by David Reardon, MD Video

ASCO22: Glioblastoma research by David Reardon, MD

Glioblastoma study shows combination immunotherapy is safe and early data on effectiveness is encouraging. Dana-Farber's David Reardon, MD, details more at #ASCO22 about the combination of a potent vaccine platform with immune checkpoint blockade.